Sign in
RFCS Stock Price, Chart, Stats & News
Refocus Group, Inc.
Save
Refocus Group, Inc. (RFCS) does not currently pay a dividend.
25
Market cap
–
Current P/E
–
Forward P/E
RFCS chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Medical - Devices
Industry
Refocus Group, Inc. is a medical technology firm dedicated to the research and creation of therapies for various human vision conditions, particularly presbyopia. A key offering is the VisAbility Micro-Insert System, an experimental medical device currently undergoing clinical evaluations for its application in treating presbyopia affecting both eyes. The organization caters to the needs of both patients and ophthalmic professionals.
Similar securities
Based on sector and market capitalization
Report issue